These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1554515)

  • 1. The pathogenesis of Pseudomonas aeruginosa lung infections in cystic fibrosis.
    Grimwood K
    J Paediatr Child Health; 1992 Feb; 28(1):4-11. PubMed ID: 1554515
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudomonas aeruginosa infection and cystic fibrosis.
    Kato K; Takayama T
    Lancet; 2002 Jan; 359(9302):262. PubMed ID: 11812595
    [No Abstract]   [Full Text] [Related]  

  • 3. Lung infections. 3. Pseudomonas aeruginosa and other related species.
    Wilson R; Dowling RB
    Thorax; 1998 Mar; 53(3):213-9. PubMed ID: 9659359
    [No Abstract]   [Full Text] [Related]  

  • 4. Colonisation of cystic fibrosis patients by non-mucoid Pseudomonas aeruginosa--characterisation of the alginate from mucoid variants.
    Tatnell PJ; Russell NJ; Govan JR; Gacesa P
    Biochem Soc Trans; 1996 Aug; 24(3):406S. PubMed ID: 8878950
    [No Abstract]   [Full Text] [Related]  

  • 5. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?].
    David V
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143
    [No Abstract]   [Full Text] [Related]  

  • 6. Unusual mechanism of pathogenicity of Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Tümmler B
    Infection; 1987; 15(4):311-2. PubMed ID: 3117705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic science for the chest physician: Pseudomonas aeruginosa and the cystic fibrosis airway.
    Williams HD; Davies JC
    Thorax; 2012 May; 67(5):465-7. PubMed ID: 22382597
    [No Abstract]   [Full Text] [Related]  

  • 8. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis.
    Pier GB; Grout M; Zaidi TS; Goldberg JB
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 2):S175-82. PubMed ID: 8876538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.
    Poschet JF; Boucher JC; Firoved AM; Deretic V
    Methods Enzymol; 2001; 336():65-76. PubMed ID: 11398420
    [No Abstract]   [Full Text] [Related]  

  • 10. Mixed morphotype susceptibility testing of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Dunne WM; Chusid MJ
    Diagn Microbiol Infect Dis; 1987 Feb; 6(2):165-70. PubMed ID: 3102157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas cross-infection from cystic fibrosis patients to non-cystic fibrosis patients: implications for inpatient care of respiratory patients.
    Robinson P; Carzino R; Armstrong D; Olinsky A
    J Clin Microbiol; 2003 Dec; 41(12):5741. PubMed ID: 14662972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory tract infections in cystic fibrosis.
    Weiner DJ
    Pediatr Ann; 2002 Feb; 31(2):116-23. PubMed ID: 11862722
    [No Abstract]   [Full Text] [Related]  

  • 13. [What microbiological criteria define a colonization or an infection with Pseudomonas aeruginosa?].
    Plésiat P
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S84-9. PubMed ID: 12910139
    [No Abstract]   [Full Text] [Related]  

  • 14. Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections.
    Tümmler B; Kiewitz C
    Mol Med Today; 1999 Aug; 5(8):351-8. PubMed ID: 10431168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.
    Pier GB; Grout M; Zaidi TS; Olsen JC; Johnson LG; Yankaskas JR; Goldberg JB
    Science; 1996 Jan; 271(5245):64-7. PubMed ID: 8539601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa.
    Petersen NT; Høiby N; Mordhorst CH; Lind K; Flensborg EW; Bruun B
    Acta Paediatr Scand; 1981 Sep; 70(5):623-8. PubMed ID: 6798822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiresistant pulmonary infection in cystic fibrosis--prevention is better than cure.
    Smyth A
    Lancet; 2005 Aug 6-12; 366(9484):433-5. PubMed ID: 16084235
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and dynamics of Lactobacillus sp. in the lower respiratory tract of patients with cystic fibrosis.
    Fangous MS; Lazzouni I; Alexandre Y; Gouriou S; Boisramé S; Vallet S; Le Bihan J; Ramel S; Héry-Arnaud G; Le Berre R
    Res Microbiol; 2018; 169(4-5):222-226. PubMed ID: 29800681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa infection in cystic fibrosis: prevent, eradicate or both?
    Eber E; Zach MS
    Thorax; 2010 Oct; 65(10):849-51. PubMed ID: 20861286
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrinsic and environmental mutagenesis drive diversification and persistence of Pseudomonas aeruginosa in chronic lung infections.
    Rodríguez-Rojas A; Oliver A; Blázquez J
    J Infect Dis; 2012 Jan; 205(1):121-7. PubMed ID: 22080096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.